Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies

Overview of attention for article published in Frontiers in immunology, July 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 47,849 followers.

RT @FrontImmunol: Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and… https://t.co/wnW…

RT @FrontImmunol: Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and… https://t.co/wnW…

RT @FrontImmunol: Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and… https://t.co/wnW…

RT @FrontImmunol: Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and… https://t.co/wnW…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.